Table 2.1 Top Therapeutic Classes by Total Expenditures, 2011
Therapeutic class |
Total expenditures ranking |
Total expenditures |
Total number of persons with expenditures |
Metabolic Agents |
1 |
50,973,919,615 |
55,896,043 |
Central Nervous System Agents |
2 |
39,036,304,924 |
83,782,498 |
Coagulation Modifiers |
3 |
27,095,980,214* |
10,878,762 |
Cardiovascular Agents |
4 |
24,566,679,178 |
69,981,148 |
Psychotherapeutic Agents |
5 |
24,266,757,855 |
31,717,450 |
Respiratory Agents |
6 |
23,151,659,258 |
37,961,281 |
Miscellaneous Agents |
7 |
18,430,108,339 |
6,602,598 |
Gastrointestinal Agents |
8 |
17,909,705,697 |
30,542,642 |
Anti-Infectives |
9 |
15,296,339,407 |
72,408,788 |
Immunologic Agents |
10 |
12,250,033,283 |
## |
Standard Errors for Table 2.1: Top Therapeutic Classes by Total Expenditures, 2011
Therapeutic class |
Total expenditures |
Total number of persons with expenditures |
Metabolic Agents |
1,932,855,841 |
1,487,787 |
Central Nervous System Agents |
1,898,300,500 |
2,030,825 |
Coagulation Modifiers |
13,584,062,214* |
482,090 |
Cardiovascular Agents |
906,090,271 |
1,731,161 |
Psychotherapeutic Agents |
1,512,255,074 |
974,758 |
Respiratory Agents |
1,231,944,367 |
1,237,986 |
Miscellaneous Agents |
2,772,477,191 |
351,015 |
Gastrointestinal Agents |
1,229,061,369 |
937,606 |
Anti-Infectives |
2,233,140,043 |
2,214,414 |
Immunologic Agents |
2,337,484,719 |
## |
## Less than 100 sample persons.
* Relative standard error equal to or greater than 30%.
Return To Top
|